Tarsons Products Limited

₹320.25As of Sun 8 Nov 2026, 12:00 UTC
NSE:TARSONSHealthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR (14.51%)
Div yield —
ROE 2.27%
Medical Instruments & Supplies
Beta (5Y) 0.33
PE TTM 154.4
TSR TTM 10.79%
Mkt cap ₹17.04B
ROIC 0.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹380
18.81%
352.01%
Hold 3|1|11|10|0
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
6.00
6.62
7.33
7.15
18.03%
21.32%
36.70%
24.66%
Revenue₹B
0.961
1.003
1.050
1.040
10.17%
10.16%
9.53%
6.10%
Peers (US$179.2M)
Cap (US$)
PE
1.743B
51.42x
115.9M
33.73x
170.7M
26.53x
Capital
TTM
5Y
10Y
Leveragex
0.714
2.478
1.865
EBIT/Intx
0.864
0.060
0.071
Own earn%
(37.34)
(98.69)
(106.54)
Sh yield%
32.06
23.94
24.77
Owners
Insiders/Inst%
14.86
69.11
Short interest%
4.00
SBC / revenue%
1.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
6–13
$1 testx
−0.1
Incr. ROIC%
1